congenital immunodeficiency
Showing 1 - 1 of 1
Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco
Terminated
- Myeloid Malignancy
- +5 more
- Alemtuzumab
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 25, 2020